WNY Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$790K Buy
+13,024
New +$759K 0.08% 116
2025
Q3
$596K Buy
13,221
+6,826
+107% +$319K 0.06% 131
2025
Q2
$296K Buy
6,395
+272
+4% +$13.4K 0.03% 185
2025
Q1
$373K Buy
6,123
+671
+12% +$39.1K 0.04% 167
2024
Q4
$308K Sell
5,452
-2,630
-33% -$147K 0.04% 169
2024
Q3
$418K Sell
8,082
-449
-5% -$21.1K 0.05% 162
2024
Q2
$354K Buy
8,531
+469
+6% +$21K 0.05% 173
2024
Q1
$437K Buy
8,062
+39
+0.5% +$1.99K 0.07% 156
2023
Q4
$412K Sell
8,023
-80
-1% -$4.2K 0.07% 158
2023
Q3
$470K Buy
8,103
+1,047
+15% +$64.2K 0.09% 140
2023
Q2
$451K Sell
7,056
-192
-3% -$12.9K 0.1% 130
2023
Q1
$502K Sell
7,248
-364
-5% -$25.7K 0.12% 120
2022
Q4
$548K Buy
7,612
+41
+0.5% +$3.09K 0.15% 105
2022
Q3
$537K Sell
7,571
-19
-0.3% -$1.38K 0.2% 95
2022
Q2
$585K Sell
7,590
-354
-4% -$27K 0.2% 89
2022
Q1
$578K Sell
7,944
-198
-2% -$13.3K 0.18% 95
2021
Q4
$504K Sell
8,142
-1,328
-14% -$77.9K 0.15% 100
2021
Q3
$564K Buy
9,470
+1,233
+15% +$81.2K 0.19% 88
2021
Q2
$552K Buy
8,237
+728
+10% +$47.5K 0.2% 84
2021
Q1
$472K Buy
7,509
+2,868
+62% +$178K 0.19% 76
2020
Q4
$288K Buy
+4,641
New +$285K 0.15% 72

Other funds holding BMY

WNY Asset Management's BMY Position: Q1 2026 in Review

WNY Asset Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 13,024 shares worth $790K. The stake represents 0.08% of the portfolio and ranks #116 among its holdings. This is a return to the name: WNY Asset Management previously reported a position in BMY as recently as Q3 2025.

WNY Asset Management first reported a position in BMY in Q4 2020 and has held it in 21 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • WNY Asset Management held 13,024 shares of Bristol-Myers Squibb worth $790K as of Q1 2026.
  • Bristol-Myers Squibb was a new WNY Asset Management position in Q1 2026.
  • Bristol-Myers Squibb made up 0.08% of WNY Asset Management's portfolio in Q1 2026, its #116 holding.
  • WNY Asset Management first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 21 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on WNY Asset Management's 13F filing for Q1 2026, filed 22 May 2026.